TWiV 870: COVID-19 clinical update #103 with Dr. Daniel Griffin

In COVID-19 clinical update #102, Daniel Griffin covers immunocompromised people, hospitalization of children, vaccine usage update, Omicron and cross-reactive neutralizing antibodies, reinfection prevents disease in hamsters, repeated infections with endemic coronaviruses, global burden of antimicrobial resistance, ivermectin not protective in hamsters, and Omicron evades therapeutic monoclonals.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• What does society owe immunocompromised people (Atlantic)
• Prevalence of immunosuppression in US (JAME)
• Hospitalizations of children (MMWR)
• Clinical considerations for vaccines (CDC)
• Sanofi seeks vaccine approval (Sanofi)
• Omicron triggers cross-reactive neutralization (medRxiv)
• Reinfection prevents disease in hamsters (Cell)
• Repeated infections with endemic CoV (J Inf Dis)
• Global burden of antimicrobial resistance (Lancet)
• Ivermectin not protective in hamsters (bioRxiv)
• Omicron evades therapeutic monoclonals (bioRxiv)
• Letters read on TWiV 870
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv